The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-N-(6,7-Dihydro-4H-[1,3]dioxolo[4',5':7,8]isoquinolino-[3,2-a][1,3]dioxolo[4,5-g]isoquinolin-4-ylidene)octanamide ID: ALA4543529
PubChem CID: 155510580
Max Phase: Preclinical
Molecular Formula: C27H28N2O5
Molecular Weight: 460.53
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCCC(=O)/N=c1\c2c3c(ccc2cc2n1CCc1cc4c(cc1-2)OCO4)OCO3
Standard InChI: InChI=1S/C27H28N2O5/c1-2-3-4-5-6-7-24(30)28-27-25-18(8-9-21-26(25)34-16-31-21)12-20-19-14-23-22(32-15-33-23)13-17(19)10-11-29(20)27/h8-9,12-14H,2-7,10-11,15-16H2,1H3/b28-27+
Standard InChI Key: VTTRQFSCZUXPGV-BYYHNAKLSA-N
Molfile:
RDKit 2D
34 39 0 0 0 0 0 0 0 0999 V2000
2.7366 -11.4412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7348 -9.8036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4435 -10.2088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4469 -11.0342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8697 -10.2030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1526 -9.7910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0283 -11.0322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0296 -10.2109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2489 -9.9560 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7652 -10.6196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2470 -11.2847 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8730 -11.0284 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1593 -11.4438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1622 -12.2649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5897 -11.4343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5909 -12.2617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8744 -12.6813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8797 -13.5069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5996 -13.9192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3124 -12.6677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3173 -13.5039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1141 -13.7577 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6017 -13.0782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1062 -12.4046 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.2955 -11.0221 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0838 -11.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6647 -10.6623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2916 -12.0279 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.4569 -9.8718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0376 -9.2966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8299 -8.5062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4162 -7.9256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2065 -7.1275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7928 -6.5469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7 1 1 0
1 4 2 0
3 2 2 0
2 8 1 0
3 4 1 0
3 6 1 0
4 13 1 0
12 5 1 0
5 6 1 0
7 8 2 0
8 9 1 0
9 10 1 0
10 11 1 0
11 7 1 0
12 13 1 0
12 15 1 0
13 14 2 0
14 17 1 0
16 15 1 0
16 17 2 0
16 20 1 0
17 18 1 0
18 19 2 0
19 21 1 0
20 21 2 0
21 22 1 0
22 23 1 0
23 24 1 0
24 20 1 0
15 25 2 0
25 26 1 0
26 27 1 0
26 28 2 0
27 29 1 0
29 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 460.53Molecular Weight (Monoisotopic): 460.1998AlogP: 5.11#Rotatable Bonds: 6Polar Surface Area: 71.28Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.75CX LogD: 4.75Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.48Np Likeness Score: 0.15
References 1. Xie M, Zhang HJ, Deng AJ, Wu LQ, Zhang ZH, Li ZH, Wang WJ, Qin HL.. (2016) Synthesis and Structure-Activity Relationships of N-Dihydrocoptisine-8-ylidene Aromatic Amines and N-Dihydrocoptisine-8-ylidene Aliphatic Amides as Antiulcerative Colitis Agents Targeting XBP1., 79 (4): [PMID:26981782 ] [10.1021/acs.jnatprod.5b00807 ]